Actions - Analyst Notes on P&G, Colgate-Palmolive, Herbalife, Unilever and Avon
07/10 05:40 CDT
Upcoming Earnings Results, Partnership for Promotions, and Restructuring Actions - Analyst Notes on P&G, Colgate-Palmolive, Herbalife, Unilever and AvonEditor Note: For more information about this release, please scroll to bottom. NEW YORK, July 10, 2014
NEW YORK, July 10, 2014 /PRNewswire/ --
Today, Analysts Review released its analysts' notes regarding Procter & Gamble Co. (NYSE: PG), Colgate-Palmolive Co. (NYSE: CL), Herbalife Ltd. (NYSE: HLF), Unilever NV (NYSE: UN) and Avon Products Inc. (NYSE: AVP). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/4642-100free. --Procter & Gamble Co. Analyst Notes On July 3, 2014, Procter & Gamble Co. (P&G) announced that the Company will webcast a discussion of its Q4 FY 2014 earnings results on Friday, August 1, 2014, beginning at 8:30 a.m. ET. To access the webcast and replay, interested parties may log on to P&G's website. The full analyst notes on P&G are available to download free of charge at:http://www.analystsreview.com/Jul-10-2014/PG/report.pdf --Colgate-Palmolive Co. Analyst Notes On July 7, 2014, Colgate-Palmolive Co.'s (Colgate-Palmolive) stock rose 0.06%, ending the day at $68.86. Over the previous three trading sessions, shares of Colgate-Palmolive increased 0.55% compared to the Dow Jones Industrial Average which climbed 0.40% during the same period. The full analyst notes on Colgate-Palmolive are available to download free of charge at:http://www.analystsreview.com/Jul-10-2014/CL/report.pdf --Herbalife Ltd. AnalystNotes On June 30, 2014, Herbalife Ltd. (Herbalife) announced that the Company will release its Q2 2014 financial results after the close of trading on the New York Stock Exchange on July 28, 2014. Herbalife's senior management team will host an investor conference call the following day, July 29, 2014, at 8:00 a.m. PT/11:00 a.m. ET to discuss its financial results and provide an update on current business trends. The full analyst notes on Herbalife are available to download free of charge at:http://www.analystsreview.com/Jul-10-2014/HLF/report.pdf --Unilever NV Analyst Notes On July 7, 2014, Unilever NV (Unilever) introduced The Unilever Foundry, the mentorship programme that the Company has been piloting over the last 18 months through start-up accelerators around the world. Unilever has partnered with Collider, a B2Brand accelerator, in the UK, through which the Company Mentors working with Collider's marketing and advertising tech startups to help them develop their propositions and secure pilots. Unilever stated that both parties are seeing the benefits: while Unilever gets access to the latest marketing technology and exposes its team to new ways of working, five Collider startups have signed revenue-generating deals with Unilever brands. The full analyst notes on Unilever are available to download free of charge at:http://www.analystsreview.com/Jul-10-2014/UN/report.pdf --Avon Products Inc. Analyst Notes On June 23, 2014, Avon Products Inc. (Avon) announced additional actions as part of the Company's ongoing turnaround efforts to return Avon to sustainable, profitable growth. According to Avon, these steps in relation to continued efforts to right size the cost structure, improve organizational effectiveness, streamline processes to gain efficiencies and reduce cost across the organization. Avon stated that these actions are primarily global headcount reductions of approximately 600 positions, largely in the corporate organization and North America business unit. Avon mentioned that total charges to be recorded as a result of these actions are expected to be approximately $45 million to $50 million before taxes, with approximately $40 million expected to be recorded in Q2 2014. According to Avon, the Company expects these restructuring actions to result in annualized savings of approximately $50 million to $55 million before taxes as part of the $400 million Cost Savings Initiative. The full analyst notes onAvonare available to download free of charge at:http://www.analystsreview.com/Jul-10-2014/AVP/report.pdf -- About Analysts Review We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership. =============== EDITOR'S NOTES: =============== 1. This is not company news. We are an independent source and our views do not reflect the companies mentioned. 2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. 3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public. 4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com. 5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com. 6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration. COMPLIANCE PROCEDURE Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be. NOT FINANCIAL ADVICE Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein. NO WARRANTY OR LIABILITY ASSUMED Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. CFA(r) and Chartered Financial Analyst(r) are registered trademarks owned by CFA Institute.
SOURCE Analysts Review